PENTARAY NAV HIGH-DENSITY MAPPING ECO CATHETER
Report
- Report Number
- 2029046-2022-01116
- Event Type
- Injury
- Date Received
- May 24, 2022
- Date of Event
- April 28, 2022
- Report Date
- August 29, 2022
- Manufacturer
- BIOSENSE WEBSTER INC
- Product Code
- MTD
- UDI-DI
- 10846835012217
- PMA / PMN Number
- K123837
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
THE DEVICE HAS BEEN REPORTED AS DISCARDED, THEREFORE NO PRODUCT INVESTIGATION CAN BE PERFORMED, AND THE CUSTOMER COMPLAINT CANNOT BE CONFIRMED. HOWEVER, INVESTIGATION IS IN PROGRESS, ONCE COMPLETED A SUPPLEMENTAL WILL BE SUBMITTED. IF ADDITIONAL INFORMATION IS RECEIVED REGARDING THIS EVENT, A SUPPLEMENTAL 3500A REPORT WILL BE SUBMITTED TO THE FDA. MANUFACTURER'S REF. # (B)(4).
IT WAS REPORTED THAT A PATIENT UNDERWENT AN ATRIAL FIBRILLATION (AFIB) ABLATION PROCEDURE WITH A PENTARAY NAV HIGH-DENSITY MAPPING ECO CATHETER AND THE PATIENT SUFFERED CARDIAC PERFORATION. AFTER THE TRANSSEPTAL PUNCTURE THE PENTARAY NAV HIGH-DENSITY MAPPING ECO CATHETER WAS NOTED TO BE IN THE PERICARDIUM AND A BLOOD EFFUSION (PERICARDIAL EFFUSION) WAS NOTICED. THE PROCEDURE WAS INTERRUPTED, AND THE CATHETER PULLED OUT OF THE PATIENT'S HEART. THE PROCEDURE WAS NOT SUCCESSFULLY COMPLETED. THE ADVERSE EVENT WAS DISCOVERED DURING USE OF BIOSENSE WEBSTER PRODUCTS. THE PHYSICIAN¿S OPINION ON THE CAUSE OF THIS ADVERSE EVENT TO BE PROCEDURE RELATED. THE PATIENT OUTCOME OF THE ADVERSE EVENT WAS REPORTED AS IMPROVED. DEVICE INVESTIGATION DETAILS: THE DEVICE INVESTIGATION HAS BEEN COMPLETED WHICH INCLUDED PERFORMING A MANUFACTURING RECORD EVALUATION (MRE). THE MANUFACTURING RECORD EVALUATION PERFORMED FOR THE FINISHED DEVICE WITH LOT NUMBER 30704149L IDENTIFIED NO INTERNAL ACTIONS RELATED TO THE REPORTED COMPLAINT CONDITION. STILL NO DEVICE HAS BEEN RECEIVED FOR ANALYSIS, THEREFORE NO PRODUCT INVESTIGATION CAN BE PERFORMED, AND THE CUSTOMER COMPLAINT CANNOT BE CONFIRMED. BASED ON THE COMPLETED MRE, THE H4. DEVICE MANUFACTURE DATE HAS BEEN POPULATED WITH 22-DEC-2021. IF ADDITIONAL INFORMATION IS RECEIVED REGARDING THIS EVENT, A SUPPLEMENTAL 3500A REPORT WILL BE SUBMITTED TO THE FDA. MANUFACTURER'S REF. # (B)(4).
IT WAS REPORTED THAT A PATIENT UNDERWENT AN ATRIAL FIBRILLATION (AFIB) ABLATION PROCEDURE WITH A PENTARAY NAV HIGH-DENSITY MAPPING ECO CATHETER AND THE PATIENT SUFFERED CARDIAC PERFORATION. AFTER THE TRANSSEPTAL PUNCTURE THE PENTARAY NAV HIGH-DENSITY MAPPING ECO CATHETER WAS NOTED TO BE IN THE PERICARDIUM AND A BLOOD EFFUSION (PERICARDIAL EFFUSION) WAS NOTICED. THE PROCEDURE WAS INTERRUPTED, AND THE CATHETER PULLED OUT OF THE PATIENT'S HEART. THE PROCEDURE WAS NOT SUCCESSFULLY COMPLETED. THE ADVERSE EVENT WAS DISCOVERED DURING USE OF BIOSENSE WEBSTER PRODUCTS. THE PHYSICIAN¿S OPINION ON THE CAUSE OF THIS ADVERSE EVENT TO BE PROCEDURE RELATED. THE PATIENT OUTCOME OF THE ADVERSE EVENT WAS REPORTED AS IMPROVED. A TRANSSEPTAL PUNCTURE HAD BEEN PERFORMED WITH A HEART SPAN FROM BIOSENSE WEBSTER. ABLATION WASN¿T PERFORMED, AS SUCH, THE SMARTABLATE GENERATOR WAS NOT USED. IT WAS NOTICED THAT THEY WERE IN THE PERICARDIUM DURING THE MAPPING PHASE. THIS WILL BE CODED AS CARDIAC PERFORATION BECAUSE THE PENTARAY NAV HIGH-DENSITY MAPPING ECO CATHETER WAS NOTED TO BE IN THE PERICARDIUM. THERE IS NO MENTION OF PERICARDIOCENTESIS OR SURGICAL INTERVENTION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1473790 | PENTARAY NAV HIGH-DENSITY MAPPING ECO CATHETER | CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY | MTD | BIOSENSE WEBSTER INC | D128207 | 30704149L | 10846835012217 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Required Intervention| L | 71CM TRANSSEPTAL NEEDLE| HEARTSPAN TRANSSEPTAL NEEDLE |